APA (7th ed.) Citation

Laurain, A., Metivier, S., Haour, G., Larrey, D., Dorival, C., Hezode, C., . . . group, o. b. o. t. A. H. s. (2019). Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort. BMC Infectious Diseases, 19(1), 1. https://doi.org/10.1186/s12879-019-3923-5

Chicago Style (17th ed.) Citation

Laurain, Anne, et al. "Safety and Efficacy of the Combination Simeprevir-sofosbuvir in HCV Genotype 1- and 4-mono-infected Patients from the French ANRS CO22 Hepather Cohort." BMC Infectious Diseases 19, no. 1 (2019): 1. https://doi.org/10.1186/s12879-019-3923-5.

MLA (9th ed.) Citation

Laurain, Anne, et al. "Safety and Efficacy of the Combination Simeprevir-sofosbuvir in HCV Genotype 1- and 4-mono-infected Patients from the French ANRS CO22 Hepather Cohort." BMC Infectious Diseases, vol. 19, no. 1, 2019, p. 1, https://doi.org/10.1186/s12879-019-3923-5.